Erlotinib in a patient with acute myelogenous leukemia and concomitant non-small-cell lung cancer.
Pitini
Vincenzo
V
Department of Medical Oncology, University of Messina, Messina, Italy.
Arrigo
Carmela
C
Altavilla
Giuseppe
G
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017209:Apoptosis / Q000187:drug effects; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D066246:ErbB Receptors / Q000096:biosynthesis / Q000235:genetics; D000069347:Erlotinib Hydrochloride; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009154:Mutation; D009378:Neoplasms, Multiple Primary / Q000188:drug therapy*; D011799:Quinazolines / Q000627:therapeutic use*; D012907:Smoking / Q000009:adverse effects; D014057:Tomography, X-Ray Computed
D000970:Antineoplastic Agents; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride; D066246:ErbB Receptors